SHANNON BROPHY: Open Payments
NPI 1891731642 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 111 payments from 11 companies in 2025. Trend: 2023 $1,141 · 2024 $1,155 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 29 | $566 |
| Otter Pharmaceuticals, LLC | 23 | $184 |
| SK Life Science, Inc. | 18 | $157 |
| Aucta Pharmaceuticals, Inc. | 12 | $152 |
| Neurelis, Inc. | 19 | $142 |
| JAZZ PHARMACEUTICALS INC. | 3 | $50 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| OWP Pharmaceuticals, Inc. | 2 | $34 |
| NOBELPHARMA AMERICA, LLC | 1 | $23 |
| LivaNova USA, Inc. | 1 | $22 |
Products named: Fintepla, SYMPAZAN, Briviact, Motpoly XR, VALTOCO, Nayzilam, EPIDIOLEX, ZONISADE.
Industry payments across NJ — which companies pay providers there.
